2019 Transparency Market Research, All Rights Reserved

Transcription

1 Ocular Inflammation Treatment Market Segmentation by Treatment Type - Corticosteroids, Antibiotics, Monoclonal Antibodies, Immunosuppressant, Cycloplegic Agents, Antivirals; Disease Type - Anterior Uveitis, Posterior Uveitis, Panuveitis, Intermediate Uveitis; Mode of Administration - Topical, Injectables, Oral, and Others; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Drug Stores, and Forecast

2 Sr. No. Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8 Chapter 9 Chapter 10 Chapter 11 Chapter 12 Chapter 13 Chapter 14 Content Preface Assumptions and Research Methodology Market Overview Market Dynamics Global Ocular Inflammation Treatment Market Analysis and Forecasts, By Software Type Global Ocular Inflammation Treatment Market Analysis, by Modality Global Ocular Inflammation Treatment Market Analysis, by Application Global Ocular Inflammation Treatment Market Analysis, by End-user Global Ocular Inflammation Treatment Market Analysis and Forecast by Region Europe Ocular Inflammation Treatment Market Analysis and Forecast Asia Pacific Ocular Inflammation Treatment Market Analysis and Forecast Latin America Ocular Inflammation Treatment Market Analysis and Forecast Middle East & Africa Ocular Inflammation Treatment Market Analysis and Forecast Competition Landscape

3 Eye inflammations or uveitis are becoming a common problem for people across global geographies. New drugs are being discovered to treat ocular inflammations, and companies are investing millions for their approval through regulatory pipelines. Patients are exhibiting a particular preference to the type of ocular inflammation treatment being adopted, considering the range of treatment options, their comparative effectiveness, and convenience in terms of mode of administration. The global market for ocular inflammation treatment is expected to grow sharply in the coming years.

4

5 Key projections from the study assess the global ocular inflammation treatment market to touch a US$ 1 billion value by the end of Increasing contamination of environment by emission of toxins has elevated the risks of ocular inflammation, also known as uveitis. Evolving medical technologies and drug discovery developments have paved way for effective treatment of ocular inflammation. Prominent market players are diversifying their product lines to cater treatment of all forms of uveitis occurring worldwide.

6 Regulatory stance of the FDA towards clearing uveitis drugs from the pipelines is improving, and market players are being favored to introduce novel administration techniques for ocular inflammation treatments. During the period of assessment, , the global market for ocular inflammation treatments is pegged to expand at a CAGR of 6.9% in terms of value. In addition to Allergan, TMR also observes high stakes of Novartis AG, Valeant Pharmaceuticals International, Inc., Abbvie, Inc., Alimera Sciences, Inc., Eyegate Pharmaceuticals, Inc., psivida Corp., Pfizer, Inc., Cipla Ltd., and Akorn, Inc. in the global ocular inflammation treatment market over the coming years.

7 To know more about us, please visit our website For sales queries or new topics us on: Thank You